Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
41 results
  • Colorectal Cancer, Melanoma, Lung Cancer, Ovarian Cancer, Breast Cancer

20-079          Phase I

A First-in-Human Phase 1b Dose Escalation Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATRC-101 in Adults with Advanced Solid Malignancies (View details on clinicaltrial.gov)

  • Head and Neck Cancer, Leukemia, Sarcoma, Lymphoma, Metastatic/Advanced Cancer, Ovarian Cancer, Breast Cancer

20-035          Phase II

A Multi-Center, Open Label Phase 1/2 Study of CYT-0851, an Oral RAD51 Inhibitor, in Patients With Relapsed/Refractory B-Cell Malignancies and Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Breast Cancer, Lung Cancer, Ovarian Cancer, Colorectal Cancer

20-211          Phase I

A Phase 1 Study of SY-5609, an Oral, Selective CDK7 Inhibitor, in Adult Patients With Select Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Lung Cancer, Breast Cancer, Ovarian Cancer, Colorectal Cancer, Endometrial Cancer

20-444          Phase I

A Phase 1, First-in-human Study of the Safety, Single- and Multiple-Dose Pharmacokinetics, and Preliminary Activity of Escalating Doses of RBN-2397, an Oral PARP7 Inhibitor, in Patients with Solid Tumors (View details on clinicaltrial.gov)

  • Melanoma, Head and Neck Cancer, Breast Cancer

20-135          Phase I

A Phase 1, Open-Label, Multicenter, Dose Escalation and Expansion Study of ONCR-177, an Oncolytic Herpes Simplex Virus for Intratumoral Injection, Alone and in Combination with PD-1 Blockade in Adult Subjects with Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors (View details on clinicaltrial.gov)

  • Esophageal Cancer, Gastric (Stomach) Cancer, Lung Cancer, Breast Cancer

20-208          Phase I

A Phase 1/1B, Open-Label, Dose Escalation and Expansion Study of SBT6050 in Subjects With Advanced Solid Tumors Expressing HER2 (View details on clinicaltrial.gov)

  • Breast Cancer

17-371          Phase II

A Phase 1/2 study for the safety, efficacy, pharmacokinetic and pharmacodynamics evaluation of SAR439859, administered orally as monotherapy, then in combination with other anti-cancer therapies in postmenopausal women with estrogen receptor-positive advanced breast cancer (View details on clinicaltrial.gov)

  • Breast Cancer

20-449          Phase II

A Phase 1/2, open-label, dose escalation, and cohort expansion clinical trial to evaluate the safety, tolerability, and pharmacokinetics of ARV-471 in patients with ER+/HER2- locally advanced or metastatic breast cancer, who have received prior hormonal therapy and chemotherapy in the locally advanced/metastatic setting (View details on clinicaltrial.gov)

  • Head and Neck Cancer, Kidney Cancer, Lung Cancer, Ovarian Cancer, Melanoma, Bladder Cancer, Breast Cancer

21-329          Phase II

A Phase 1a Open-Label, Dose-Escalation, and a Phase 2 Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of ST-067 Administered Subcutaneously as Monotherapy in Patients with Relapsed or Refractory Solid Tumors (View details on clinicaltrial.gov)

  • Breast Cancer

20-118          Phase I

A Phase 1a/1b Study of LY3484356 Administered as Monotherapy and in Combination with Abemaciclib to Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer and Other Select Non-Breast Cancers (View details on clinicaltrial.gov)

Showing 1 - 10 of 41 results